Aspire Biopharma Stock (NASDAQ:ASBP)


OwnershipChart

Previous Close

$0.09

52W Range

$0.07 - $15.80

50D Avg

$0.24

200D Avg

$0.41

Market Cap

$5.18M

Avg Vol (3M)

$36.36M

Beta

0.87

Div Yield

-

ASBP Company Profile


Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Apr 11, 2022

Website

ASBP Performance


Peer Comparison


TickerCompany
DAREDaré Bioscience, Inc.
HOTHHoth Therapeutics, Inc.
PCSAProcessa Pharmaceuticals, Inc.
ADTXAditxt, Inc.
BCTXBriaCell Therapeutics Corp.
CRISCuris, Inc.
LPTXLeap Therapeutics, Inc.
CTXRCitius Pharmaceuticals, Inc.
PALIPalisade Bio, Inc.